Tetsuya TSUKAMOTO is a full time Professor in the Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan. Medical Doctor (1987) in Mie University School of Medicine, Tsu, Japan and Doctor of Philosophy (1991) in Mie University Graduate School of Medicine, Tsu, Japan. Worked in cancer research in Aichi Cancer Center Research Institute, Nagoya, Japan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, and University of California at Berkeley, Berkeley, CA, USA. Involved in Pathological field in Division of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya and Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan, steering the clinical, teaching, training and research works. Member of Digital Pathology Association, Japan, Japanese Society of Pathology, Japanese Society of Clinical Cytology, Japanese Society of Toxicologic Pathology, and Japanese Cancer Association. He has over 200 peer reviewed research publications in oncological and experimental pathology and more than 20 book chapters to his credit. Currently he is involved in image analysis using deep learning and computer-aided detection/diagnosis in pathological cytological fields.
Donghui Cao   Zhifang Jia   Yanhua Wu   Tongrong Su   Dan Zhao   Menghui Wu   Tetsuya Tsukamoto   Masanobu Oshima   Jing Jiang   Xueyuan Cao   
Life sciences 263 118580-118580 2020年10月
Aberrant methylation of promoter CpG islands (CGIs) can inactivate the expression of many tumor suppressor genes and play an important role in the carcinogenesis of gastric cancer. The tumor suppressor gene RB1, which encodes a cell cycle regulato...
Only a small percentage of patients afflicted with gastric cancer (GC) respond to immune checkpoint blockade (ICB). To study the mechanisms underlying this resistance, we examined the immune landscape of GC. A subset of these tumors was characteri...
BACKGROUND: The prevalence of Barrett's esophageal adenocarcinoma (BEA) is increasing in Japan. Accurate assessment of lymphovascular invasion (LVI) after endoscopic resection or surgery is essential in evaluating treatment response. This study ai...